Canadian National Pharma Group
Abbotsford, Canada
Canadian National Pharma Group Inc.
Canonical Listing Details
The native directory details remain the canonical public source for this profile.
Marcus Dahl is a prototypical intrapreneur. He has built his entire career by taking direct responsibility for turning an idea into a profitable finished product through assertive risk-taking and innovation. He has creative problem-solving and an eye for areas that can be streamlined, he drives consistent bottom-line improvements and shareholder returns. Marcus is excited to be working in the world of international pharmaceuticals as he sees the potential for growth financially but also as a way of improving world health overall. With a background in business growth, sales, new market development and staff supervision, Marcus moves the company forward with a fine balance of fiscal restraint, accountability and risk management.
Canadian National Pharma Group received its Health Canada processing licence on November 29, 2019.
Unlock enhanced profile insights
Create a free account to view AI-powered profile details, related companies, and richer market signals.
Unlock enhanced profile insights
Create a free account to view AI-powered profile details, related companies, and richer market signals.
Unlock enhanced profile insights
Create a free account to view trust, completeness, and freshness signals for this profile.
